• 1
    Australian Bureau of Statistics. National Health Survey: SF36 Population Norms Australia. Canberra : ABS; 1997.
  • 2
    McCallum J. The SF-36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health 1995;19(2):1606.
  • 3
    Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF-36 health survey questionnaire: an outcome measure suitable for use within the NHS Br Med J 1993;306:14404.
  • 4
    Lyons RA, Perry HM, Littlepage BNC. Evidence for the validity of the short-form 36 questionnaire (SF-36) in an elderly population. Age Aging 1994;23:1824.
  • 5
    Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. Br Med J 1992;305:1604.
  • 6
    Jenkinson C, Coulter A, Wright L. Short form (SF 36) health survey questionnaire: Normative data for adults of working age. Br Med J 1993;306:143740.
  • 7
    McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31(3):24763.
  • 8
    Special issue, J Clin Epidemiol 1998;51(11).
  • 9
    Deyo RA, Inui TS, Leininger JD, Overman SS. Measuring functional outcomes in chronic disease: A comparison of traditional scales and a self administered health status questionnaire in patients with rheumatoid arthritis. Med Care 1983;21(2):18092.
  • 10
    Hunt SM, McEwan J, McKenna SP. Measuring Health Status. Beckenham : Croom Helm; 1986.
  • 11
    Hall J, Hall N, Fisher E, Killer D. Measurement of outcomes of general practice: Comparison of three health status measures. Fam Practice 1987;4:11723.
  • 12
    Kind P, Carr-Hill R. The Nottingham health profile: a useful tool for epidemiologists Soc Sci Med 1987;25:90510.
  • 13
    Bowling A. Measuring Disease. Buckingham : Open University Press; 1995. p 281.
  • 14
    McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32(1):4466.
  • 15
    Garratt AM, Macdonald LM, Ruta DA, Russell IT, Buckingham JK, Krukowski ZH. Towards measurement of outcome for patients with varicose veins. Qual Health Care 1993;2:510.
  • 16
    Bousquet J, Knani J, Dhivert H, Richard A, Chicoye A, Ware JE, et al. Quality of life in asthma: I Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994;149:3715.
  • 17
    Osterhaus JT, Townsend RJ, Gandek B, Ware JE. Measuring the functional status and well-being of patients with migraine headache. Headache 1994;34:33743.
  • 18
    Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of Life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument. Annu Intern Med 1992;116:12937.
  • 19
    Phillips RC, Lansky DJ. Outcomes management in heart valve replacement surgery: Early experience. J Heart Valve Dis 1992;1(1):4250.
  • 20
    Kantz ME, Harris WJ, Levitsky K, Ware JE, Davies AR. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement. Med Care 1992;30(5 Suppl): MS240252.
  • 21
    Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 1999;44(4):52733.
  • 22
    Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and the United Kingdom. Digestion 1999;60(1):7781.
  • 23
    Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:92734.
  • 24
    Heaton KW, O'Donnell LJD, Braddon FEM, Mountford RA, Hughes AO, Cripps PJ. Irritable bowel syndrome in a British urban community: consulters and non-consulters. Gastroenterology 1992;102:19627.
  • 25
    Jones R, Lydeard S. Irritable bowel syndrome in the general population. Br Med J 1992;304:8790.
  • 26
    Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995;25:3027.
  • 27
    Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics and referral. Gut 2000;46:7882.
  • 28
    Drossman DA, Li Z, Andruzzi E, Temple R, Talley NJ, Thompson WG, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993;38:156980.
  • 29
    Farthing MJG. Irritable bowel, irritable body, or irritable brain Br Med J 1995;310:1715.
  • 30
    Medical Outcomes Trust. SF-36 Health Survey Scoring Manual Language Adaptations: Australia/New Zealand, Canada, United Kingdom. Boston : Medical Outcomes Trust; 1994.
  • 31
    Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992;5:7591.
  • 32
    Talley NJ, Nyren O, Drossman DA, Heaton KW, Veldhuyzen van Zanten SJO, Koch MM, et al. The irritable bowel syndrome: Toward optimal design of controlled treatment trials. Gastroenterol Int 1993;6:189211.
  • 33
    Bensoussan A, Talley NJ, King M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. J Am Med Assoc 1998;280(18):15859.
  • 34
    Wolinsky FD, Wan GJ, Tierney WM. Changes in the SF36 in 12 months in a clinical sample of disadvantaged older adults. Med Care 1998;36(11):158998.
  • 35
    Husted JA, Gladman DD, Cook RJ, Farewell VT. Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis. J Rheumatol 1998;25(11):214655.
  • 36
    Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997;11(3):5539.